# Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
Canonical URL: https://biopharmsignal.com/news/IRWD/ironwood-pharmaceuticals-maintains-fy-2025-financial-guidance-and-announces-fy-2026-financial-guidance
Ticker: IRWD
Company: Ironwood Pharmaceuticals
Source: Ironwood Pharmaceuticals
Published: 2026-01-02 12:05 EST
Original Source URL: https://investor.ironwoodpharma.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-14 11:30 EST — [Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients](https://biopharmsignal.com/news/IRWD/ironwood-appoints-dr-jeffrey-silber-chief-medical-officer-and-head-of-research-a-b6d13a27) — Source: Ironwood Pharmaceuticals
- 2026-05-28 20:05 EST — [Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/IRWD/ironwood-pharmaceuticals-to-participate-in-the-jefferies-global-healthcare-confe-b815d20d) — Source: Ironwood Pharmaceuticals
- 2026-05-27 14:00 EST — [FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)](https://biopharmsignal.com/news/IRWD/fda-approves-use-of-linzessr-linaclotide-in-pediatric-patients-two-years-of-age-and-older-with-functional-constipation-fc) — Source: Ironwood Pharmaceuticals
- 2026-05-07 11:05 EST — [Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance](https://biopharmsignal.com/news/IRWD/ironwood-pharmaceuticals-reports-strong-first-quarter-2026-results-with-97-year-over-year-linzess-u-s-net-sales-growth-maintains-full-year-2026-financial-guidance) — Source: Ironwood Pharmaceuticals
- 2026-05-04 11:05 EST — [Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)](https://biopharmsignal.com/news/IRWD/ironwood-survey-findings-at-ddw-2026-underscore-need-for-therapies-that-address-multiple-dimensions-of-total-parenteral-nutrition-tpn-burden-in-short-bowel-syndrome-sbs) — Source: Ironwood Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)